Background: The association of an increased risk to develop melanoma in patients with prostate cancer has recently been confirmed. Purpose: The postulated etiologic relationship between prostate cancer and the subsequent occurrence of melanoma is discussed. Methods: A man with previous prostate cancer who developed melanoma on the plantar surface of his left great toe is described and the possibility of high levels of endogenous androgens promoting not only prostate cancer, but also increased risk of melanoma are reviewed. Results: Modification of the host immune response, alteration of chromosome telomere length, and/or imbalance of androgen level (presenting as severe teenage acne) are potential mechanisms whereby high levels of endogenous androgens may contribute to the association between prostate cancer and risk of melanoma. Conclusions: An increased surveillance for melanoma should be considered in prostate cancer patients. Complete skin examination in men who have had prostate cancer-especially in those individuals diagnosed with prostate cancer prior to age 68 years-should regularly be performed.
INTRODUCTION
Melanoma is the fifth most commonly diagnosed cancer among men in the United States and may, in part, be etiologically associated with androgen levels or androgen receptors in the tumor or both [1] [2] [3] [4] [5] [6] . Prostate cancer is an androgen-related malignancy [7] [8] [9] [10] [11] . The statistically significant development of malignant melanoma in prostate cancer patients has recently been confirmed [12] . A man with previous prostate cancer who developed melanoma on the plantar surface of his left Electronic supplementary material The online version of this article (doi:10.1007/s13555-014-0045-2) contains supplementary material, which is available to authorized users. great toe is described and the postulated etiologic relationship between prostate cancer and the subsequent occurrence of melanoma is discussed.
All All three of the pigmented patches, in addition to 5 mm of normal-appearing adjacent skin, were excised were also biopsied; microscopic examination showed melanocytic hyperplasia and atypical intraepidermal melanocytic proliferation, respectively. With regard to management, treatment of the latter diagnosis is similar to that of melanoma in situ.
Complete excision of all three black-brown patches, including an additional 5 mm margin of normal-appearing skin, was performed and the wound was covered with a full-thickness skin graft.
DISCUSSION
Carcinoma of the prostate is the most common non-cutaneous cancer in the United States [2] . Earlier epidemiology studies have observed an increase in melanoma in men with a history of prostate cancer [13, 14] . Recently, Li et al.
prospectively examined this issue and confirmed the association between a personal history of prostate cancer and an increased risk of subsequent melanoma in white men [12, 15, 16] .
High levels of endogenous androgens have been postulated to contribute to the association between prostate cancer and risk of melanoma.
Possible androgen-associated mechanisms of pathogenesis have been hypothesized. Some of these include host immune response modification, chromosome telomere length alteration, and androgen level imbalance [9] [10] [11] . A compromised immune response may affect the individual's risk of developing melanoma.
Indeed, the host's immune response can be suppressed by androgens, promoting tumorigenesis of not only prostate cancer but also melanoma. In contrast, immunotherapy is a potential therapeutic intervention for prostate cancer and a patient's response to melanoma vaccine and survival can both be improved after their immune status has been enhanced following a blocking or elimination of androgen signaling [17] [18] [19] [20] [21] .
Telomeres are the tiny bits of DNA that cap the ends of chromosomes [22] . They prevent chromosomes from unraveling and fusing with each other. Telomeres shorten not only as people age but also each time a cell divides; eventually, the cell dies when the telomere becomes too short [22, 23] . However, an increased risk of melanoma has been associated with long telomeres [24] .
Telomerase is an anti-aging enzyme [22, 23] .
It protects telomeres from wearing down and rebuilds them. Androgen exposure in vitro has been demonstrated to stimulate telomerase activity resulting in elongation of telomeres and extension of melanocyte life span [25] .
Hence, by increasing telomere DNA replication and subsequent telomere length, androgens may influence the risk of melanoma development [26, 27] .
Androgen imbalance may be an integral component in the tumorigenesis of not only prostate cancer, but also the enhanced susceptibility to develop melanoma. An early clinical manifestation of androgen imbalance is acne [28] . Patients with severe acne, defined by use of tetracycline for four or more years, have an increased risk of prostate cancer [28, 29] . Li et al. [12] also observed a significant positive association between severe teenage acne and melanoma risk.
The patient in this report had moderate to severe acne as a teenager which may represent an early indication of androgen imbalance. He received tetracycline for at least 3 years when he was in high school. He developed prostate cancer at the age of 51 years. Subsequently, he developed melanoma in situ on the sun protected plantar left big toe. Similar to this man, Li et al. [12] also observed a higher hazard ratio of melanoma among patients with prostate cancer whose median age at diagnosis was less than or equal to 68 years. 
CONCLUSION
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